Long-term Follow-up of Children Born in the PETN Studies
NCT06534307 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 228
Last updated 2024-08-02
Summary
In every 10th pregnancy, the child in the uterus is insufficiently nourished, a so-called growth retardation. This occurs when the child cannot reach its growth potential due to an undersupply in the uterus. This inadequate supply is considered a developmental cause for the later development of physical diseases like cardiovascular diseases, sugar metabolism disorders and obesity as well as mental developmental problems (for example problems in cognitive skills, deficits in language development, concentration and attention).
From 2002 to 2008, 111 patients with impaired placental blood flow were included in a small study and treated with Pentalong or placebo. From 2017 to 2022, the positive effects of the study treatment were tested on a larger number of patients. A total of 317 pregnant women were included at 14 participating study centers in Germany.
In this follow-up study, the development of the children born in the two studies will be examined. The study consists of two independent parts: firstly, questionnaires are answered by the former participants and secondly, an on-site visit is carried out to check the physical and mental health of the child.
Conditions
- Intrauterine Growth Restriction
- Pentaerithrityl Teratnitrate in Pregnancy
- Long-Term Effects to Children
Interventions
- BEHAVIORAL
-
Questionnaire Child Behaviour Checklist
The Child Behavior Checklist comprises items assigned to 8 subscales describing various behavioral areas. These subscales can be summed up to scores for internalizing and externalizing problems as well as a total score. Checklist scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean higher amount of problems.
- BEHAVIORAL
-
Questionnaire Young Self Report
The Questionnaire Young Self Report comprises items assigned to 8 subscales describing various behavioral areas. These subscales can be summed up to scores for internalizing and externalizing problems as well as a total score.
- DIAGNOSTIC_TEST
-
physical examination
physical development examination including height (in cm), weight (in g) and tanner states
- DIAGNOSTIC_TEST
-
metabolic examination
metabolic development using blood analysis including blood components, metabolic parameters (Glucose, HbA1c, cholestrol)
- BEHAVIORAL
-
Questionnaire Reynolds Intellectual Assessment Scales and Screening
The RIAS is standardized intelligence test. The RIAS provides an "Total Intelligence Index" (GIX, estimate of the general intelligence/g-factor), Verbal Intelligence Index (VIX) and the Nonverbal Intelligence Index (NIX). Test scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean better cognitive performance.
- DIAGNOSTIC_TEST
-
electroencephalogram
neurocognitive development
- OTHER
-
Questionnaire Movement Assessment Battery for Children
The M-ABC-2 is an standardized test to assess the motoric development. Adding up subscores addressing manual dexterity, aiming and catching, and balance delivers a total score of the motoric performance. Test scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean better performance.
- OTHER
-
Questionnaire Continuous Performance Test
The CPT measures selective attention, sustained attention as well as impulsive behavior. Checklist scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean worse performance.
- OTHER
-
Questionnaire Diagnostic System for Mental Disorders
The FBB-ADHS assesses a total score for ADHD-like behavior and subscores for the symptom trias of ADHD (attention deficit, motoric hyperactivity as well as impulsive behavior, Questionnaire scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean higher amount of symptoms.
- DIAGNOSTIC_TEST
-
kidney function tests
urine examination (proteomics, cytokines, lipidomics)
- OTHER
-
Questionnaire Five to Fifteen
The FTF 5-15R is a questionnaire to evaluate the child's developmental outcome in different areas of everyday life (cognition, language, and motor impairment as well as social, emotional, and behavioral problems). Individual item scores are added up per area and divided by the number of items. This results in a common scale value. Range of Percentile scores from 0 to 100 (0-90: no developmental problem; 90 and higher: hint for developmental problem). Higher scores mean worse developmental outcome.
- DIAGNOSTIC_TEST
-
cardiovacular examination
measurement of pulse wave velocity
Sponsors & Collaborators
-
Jena University Hospital
lead OTHER
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2027-03-31
- Completion
- 2028-03-31
Countries
- Germany
Study Locations
More Related Trials
-
KBTH-GIRHL Healthy Birth Weight Study: A Cross-Section
NCT03062228 ·Status: COMPLETED
-
Preeclampsia Associated Vascular Aging
NCT04484766 ·Status: UNKNOWN
-
Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU
NCT05687669 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Nicotinamide in Early Onset Preeclampsia
NCT03419364 ·Status: COMPLETED ·Phase: PHASE2
-
Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension
NCT01549444 ·Status: COMPLETED
-
Phase I Study of Nicotinamide for Early Onset Preeclampsia
NCT02213094 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth
NCT02897076 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial
NCT04835233 ·Status: COMPLETED ·Phase: PHASE4
-
China Obstetrics Alliance Cohort Study
NCT03038555 ·Status: UNKNOWN
-
Fatty Acids During Pregnancy and Lactation and Body Fat Mass in Newborns
NCT00362089 ·Status: COMPLETED ·Phase: NA
-
Management of Postpartum Preeclampsia
NCT05775744 ·Status: COMPLETED ·Phase: NA
-
Pravastatin to Prevent Preeclampsia
NCT03944512 ·Status: TERMINATED ·Phase: PHASE3
-
B-vitamin Levels and Adverse Pregnancy Outcomes
NCT05073978 ·Status: COMPLETED
-
Catestatin and Hypertension in Pregnancy
NCT03200743 ·Status: UNKNOWN
-
The Role of Pentraxin 3 and Cathepsin B Levels in Preeclamptic Pregnancy
NCT05924061 ·Status: COMPLETED
-
Angiogenic Factors in the Conservative Management of Gestational Hypertension
NCT06123377 ·Status: RECRUITING ·Phase: NA
-
Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?
NCT05640596 ·Status: COMPLETED
-
Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy
NCT00571766 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Phenylalanine Restricted Diet During Pregnancy to Prevent Symptoms in Offspring of Patients With Phenylketonuria
NCT00006142 ·Status: COMPLETED ·Phase: NA
-
B Vitamin Deficiency and Pregnancy Complications
NCT05720650 ·Status: WITHDRAWN
-
Lifestyle Intervention for Women With Recent Pre-eclampsia or Gestational Diabetes Mellitus ('Mom's Healthy Heart')
NCT03993145 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.
NCT05278793 ·Status: UNKNOWN ·Phase: PHASE4
-
Preeclampsia Postpartum Antihypertensive Treatment
NCT04298034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa
NCT05811676 ·Status: COMPLETED ·Phase: PHASE3
-
China Obstetrics Alliance Cohort Study
NCT03615560 ·Status: UNKNOWN